Paradoxical Growth of Candida albicans in the Presence of Caspofungin Is Associated with Multiple Cell Wall Rearrangements and Decreased Virulence
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Paradoxical Growth of Candida albicans in the Presence of Caspofungin Is Associated with Multiple Cell Wall Rearrangements and Decreased Virulence
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 58, Issue 2, Pages 1071-1083
Publisher
American Society for Microbiology
Online
2013-12-03
DOI
10.1128/aac.00946-13
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Candida and Host Determinants of Susceptibility to Invasive Candidiasis
- (2013) Michail S. Lionakis et al. PLoS Pathogens
- Elevated Chitin Content Reduces the Susceptibility of Candida Species to Caspofungin
- (2012) Louise A. Walker et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*
- (2012) Maiken C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- The non-mammalian hostGalleria mellonellacan be used to study the virulence of the fungal pathogenCandida tropicalisand the efficacy of antifungal drugs during infection by this pathogenic yeast
- (2012) Ana Cecilia Mesa-Arango et al. MEDICAL MYCOLOGY
- Selecting an Invertebrate Model Host for the Study of Fungal Pathogenesis
- (2012) Athanasios Desalermos et al. PLoS Pathogens
- Echinocandins: Addressing outstanding questions surrounding treatment of invasive fungal infections
- (2011) S. L. Holt et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Paradoxical Effect of Caspofungin against Candida Bloodstream Isolates Is Mediated by Multiple Pathways but Eliminated in Human Serum
- (2011) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phase II Dose Escalation Study of Caspofungin for Invasive Aspergillosis
- (2011) O. A. Cornely et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin ResistanceIn Vivo
- (2011) Keunsook K. Lee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Methods for usingGalleria mellonellaas a model host to study fungal pathogenesis
- (2011) Beth Burgwyn Fuchs et al. Virulence
- Trailing or Paradoxical Growth of Candida albicans When Exposed to Caspofungin Is Not Associated with Microsatellite Genotypes
- (2010) M. Khlif et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Changes in Cell Wall Synthesis and Ultrastructure during Paradoxical Growth Effect of Caspofungin on Four DifferentCandidaSpecies
- (2010) Fernando C. Bizerra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- EUCAST Technical Note on fluconazole
- (2010) CLINICAL MICROBIOLOGY AND INFECTION
- Chitin synthesis and fungal pathogenesis
- (2010) Megan D Lenardon et al. CURRENT OPINION IN MICROBIOLOGY
- In vivo studies with a Candida tropicalis isolate exhibiting paradoxical growth in vitro in the presence of high concentration of caspofungin
- (2010) Sedigh Bayegan et al. JOURNAL OF MICROBIOLOGY
- Paradoxical Growth of Candida dubliniensis Does Not Preclude In Vivo Response to Echinocandin Therapy
- (2009) M. Marine et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biofilm Formation and Effect of Caspofungin on Biofilm Structure of Candida Species Bloodstream Isolates
- (2009) J. A. G. Ferreira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Multicenter, Double‐Blind Trial of a High‐Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
- (2009) Robert F. Betts et al. CLINICAL INFECTIOUS DISEASES
- Fungal echinocandin resistance
- (2009) Louise A. Walker et al. FUNGAL GENETICS AND BIOLOGY
- A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility
- (2008) G. Garcia-Effron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Capsule enlargement inCryptococcus neoformansconfers resistance to oxidative stress suggesting a mechanism for intracellular survival
- (2008) Oscar Zaragoza et al. CELLULAR MICROBIOLOGY
- EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts
- (2008) J.L. Rodriguez-Tudela et al. CLINICAL MICROBIOLOGY AND INFECTION
- Epidemiology of candidemia in intensive care units
- (2008) Emilio Bouza et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth
- (2008) E. Cateau et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activation of Insect Phenoloxidase after Injury: Endogenous versus Foreign Elicitors
- (2008) Gawa Bidla et al. Journal of Innate Immunity
- Dynamic, Morphotype-Specific Candida albicans β-Glucan Exposure during Infection and Drug Treatment
- (2008) Robert T. Wheeler et al. PLoS Pathogens
- Stimulation of Chitin Synthesis Rescues Candida albicans from Echinocandins
- (2008) Louise A. Walker et al. PLoS Pathogens
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started